InMed Pharmaceuticals Inc (TSE:IN) Director Eric Ashley Adams Purchases 100,000 Shares

Share on StockTwits

InMed Pharmaceuticals Inc (TSE:IN) Director Eric Ashley Adams acquired 100,000 shares of the firm’s stock in a transaction dated Thursday, November 28th. The stock was bought at an average price of C$0.25 per share, for a total transaction of C$25,000.00. Following the completion of the acquisition, the director now owns 530,725 shares in the company, valued at approximately C$132,681.25.

InMed Pharmaceuticals stock opened at C$0.25 on Wednesday. The company has a market capitalization of $42.21 million and a PE ratio of -3.01. The company has a debt-to-equity ratio of 3.36, a quick ratio of 10.09 and a current ratio of 10.30. InMed Pharmaceuticals Inc has a fifty-two week low of C$0.22 and a fifty-two week high of C$0.80. The firm has a 50 day moving average price of C$0.26 and a 200 day moving average price of C$0.32.

InMed Pharmaceuticals (TSE:IN) last released its quarterly earnings results on Friday, November 8th. The company reported C($0.02) EPS for the quarter, hitting analysts’ consensus estimates of C($0.02). As a group, equities research analysts forecast that InMed Pharmaceuticals Inc will post -0.1122449 earnings per share for the current year.

InMed Pharmaceuticals Company Profile

InMed Pharmaceuticals Inc, a pre-clinical stage biopharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-750, a topical cannabinoid product candidate to treat epidermolysis bullosa. The company is also involved in developing INM-085, a cannabinoid-based topical therapy for glaucoma; and INM-405 for the treatment of orofacial pain.

Further Reading: Diversification Important in Investing

Insider Buying and Selling by Quarter for InMed Pharmaceuticals (TSE:IN)

Receive News & Ratings for InMed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.